Antibodies play a vital role in diagnosing and treating diseases that are usually a result of pathogens or affecting toxins. For centuries, these have has the potential to be injected into humans and treat various conditions. This has led to the birth of diverse human antibodies and has been curated as a synthetic hyper immune library for therapeutic development. 

The library mimics the function of antibodies in an in vivo human body environment and allows the antibody to develop fully to work against the target optimally. 

• Diversification of B cell Repertoire

B lymphocytes development in the early bone marrow stage is concentration with the heavy and light chain gene segments that are independent. With the rearrangement of fabrics and B cell environment expression, there is a pool of antibody synthesis with diversion above a factor of 10 to the power of 12. 

Diversification of B cell repertoire depends on the generation of diverse antibodies with two stages: pre-antigen simulation and post-antigen simulation. The pre-antigen simulation has the diverse antibody molecules count as 10 to the power of 12, that rise into the hyper immune library with therapeutic applications.

The pre-stage efficiently provides a vast number of antigens whilst it is generated by allelic diversity caused due to varied gene segments, VDJ recombination, the pairing of heavy and light chains, junctional diversity, and receptor editing. 

• Antibody Phage Display Technology

The antibody phage display technology was a revolution in the 20th Century that changed the in vitro production of antibodies. The in vitro display of phage allowed the researchers to create a generation of human monoclonal antibodies. It resulted in a higher amount of antibody production in a more controlled manner. 

This promising technology of in vitro antibody phage display technology gave birth to the hyper immune library that anticipated the customisation of antibodies with isolated mAbs and creating fragments for the degradation of infectious bacteria. 

• Construction of Naïve Antibody Library for Phage Display

The naïve antibody library is constructed with B cells of a healthy donor; the usual focus of the construction is on the immunoglobulin M (IgM) isotype. This naïve library construction leads to the usage of isolation of the mAbs against an antigen of choice.

Such a process involves naïve antibody library creation with 10 to the power of 11 with lower affinity in the human repertoire. It is a part of the hyper immune library.

• Isolation of Naïve Antibodies from Human Antibody Library Against Infectious Diseases

The antibody diagnostic allows the immune library preferred for the antibody development against the infectious agents, as they are targeted with the antibody repertoires with the infection exposure. Though the immune libraries have a high-affinity antibody generated due to the in vivo maturation cycle, there is a drawback in producing a wide range of antigens.

Hence, the significant advantage that lies with naïve antibody library is for the considerable diversity it produces and develops without any bias against antigens and is specific to every target that is aimed at.

• Naïve Library Derived Antibodies Against Target Antigens of Infectious Agents

The phage display technology, when applied to varied targets, has the ability to isolated antibodies against target antigens. The naïve antibody library used against the infectious agents has the most targeted antibody generation. 

With the contribution of naïve antibody library in discovering infectious agents and their potential antibody development, it has applied to various other diseases and has developed to higher therapeutic effect.

• Potential Applications of Antibodies Derived from Naïve Antibody Libraries

MAbs are the vital component of drugs against major autoimmune disorders, cancers, or the infectious agents with harmful antigens. With the increased precision and higher interest in the biomedical application in therapeutics with the antibodies, the antibody phage display technology has a broadway.

With this being a potential alternative for rapid discovery and broad applications, it is considered novel, specific, and fully repertoire of humans.

We at GeNext Genomics have expert technicians and experienced scientists that have the power of research and development. With this, they develop the most concentrated products with your demand and requirements.

We have a wide range of hyper immune library that produce the most targeted therapy and advanced development in response. We take pride in providing high-quality products in the market and deliver on time with customer satisfaction